Kinase inhibitors: the road ahead

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Receptor tyrosine kinase (RTK) signaling pathways are crucial in cancer, targeted for proliferation and angiogenesis inhibition.
• Kinase deregulation is implicated in a wide spectrum of major diseases beyond cancer.
• Drug discovery for kinase inhibitors has expanded to new targets and therapeutic areas.

Purpose of the Study:

• To review novel targets and biological processes for small molecule kinase inhibitors.
• To explore emerging therapeutic areas for kinase-targeted therapies.
• To assess challenges and enabling strategies in developing optimized kinase inhibitors.

Main Methods:

• Literature review of current kinase inhibitor research.
• Analysis of emerging kinase targets and their biological roles.
• Evaluation of strategies and technologies in small molecule inhibitor development.

Main Results:

• Identification of expanded kinase targets and disease areas beyond oncology.
• Overview of challenges in developing selective and effective kinase inhibitors.
• Assessment of advanced technologies facilitating inhibitor optimization.

Conclusions:

• Kinase inhibitor development is broadening significantly beyond traditional cancer applications.
• Addressing challenges in selectivity and delivery is key for new therapeutic successes.
• Technological advancements are crucial for efficient generation of optimized kinase inhibitors.